PRX-07034

From Wikipedia, the free encyclopedia
Jump to: navigation, search
PRX-07034
PRX-07034 structure.png
Clinical data
Routes of
administration
Oral
ATC code none
Legal status
Legal status
  • Uncontrolled
Identifiers
CAS Number 903580-16-5
PubChem (CID) 11532574
UNII YJ5TMF911R YesY
Chemical and physical data
Formula C21H29Cl2N3O4S
Molar mass 490.44 g/mol
3D model (Jmol) Interactive image
  (verify)

PRX-07034 is a selective 5-HT6 receptor antagonist.[1] It has cognition and memory-enhancing properties and potently decreases food intake and body weight in rodents.[1][2][3][4] PRX-07034 was under development by Epix Pharmaceuticals for the treatment of obesity and cognitive impairment associated with Alzheimer's disease and schizophrenia but upon the company collapsing due to lack of funds the compound was auctioned to another corporation.[5][6][6][7]

References[edit]

External links[edit]